SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-015647
Filing Date
2012-03-16
Accepted
2012-03-16 16:34:14
Documents
11
Period of Report
2012-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q v305842_10q.htm 10-Q 354594
2 EXHIBIT 31.1 v305842_ex31-1.htm EX-31.1 10231
3 EXHIBIT 31.2 v305842_ex31-2.htm EX-31.2 10249
4 EXHIBIT 32.1 v305842_ex32-1.htm EX-32.1 4070
5 EXHIBIT 32.2 v305842_ex32-2.htm EX-32.2 4125
  Complete submission text file 0001144204-12-015647.txt   2079943

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adxs-20120131.xml EX-101.INS 214170
7 XBRL TAXONOMY EXTENSION SCHEMA adxs-20120131.xsd EX-101.SCH 22095
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adxs-20120131_cal.xml EX-101.CAL 26418
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adxs-20120131_def.xml EX-101.DEF 79130
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adxs-20120131_lab.xml EX-101.LAB 183984
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adxs-20120131_pre.xml EX-101.PRE 105319
Mailing Address TECHNOLOGY CENTRE OF NEW JERSEY 675 ROUTE 1 NORTH BRUNSWICK NJ 08902
Business Address TECHNOLOGY CENTRE OF NEW JERSEY 675 ROUTE 1 NORTH BRUNSWICK NJ 08902 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-28489 | Film No.: 12698089
SIC: 2834 Pharmaceutical Preparations